The obesity paradox in the surgical population

Surgeon

Volumn 11, Issue 3, 2013, Pages 169-176

  Valentijn, Tabita M ^a   Galal, Wael ^a   Tjeertes, Elke K M ^a   Hoeks, Sanne E ^a   Verhagen, Hence J ^a   Stolker, Robert Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Body mass index; Mortality; Obesity paradox; Surgery

Indexed keywords

BODY MASS; COMORBIDITY; HEALTH; HUMAN; MORBIDITY; OBESITY, MORBID; RISK FACTOR; SURGERY; SURVIVAL RATE; TRENDS;

BODY MASS INDEX; COMORBIDITY; GLOBAL HEALTH; HUMANS; MORBIDITY; OBESITY, MORBID; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL RATE;

EID: 84877598067     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surge.2013.02.003     Document Type: Review

References (103)

1. Hawn M.T., Bian J., Leeth R.R., et al. Impact of obesity on resource utilization for general surgical procedures. Ann Surg 2005, 241(5):821-826.
2. Ward S.A., Parikh S., Workman B. Health perspectives: international epidemiology of ageing. Best Pract Res Clin Anaesthesiol 2011, 25(3):305-317.
3. Liu J.H., Etzioni D.A., O'Connell J.B., Maggard M.A., Ko C.Y. The increasing workload of general surgery. Arch Surg 2004, 139(4):423-428.
4. Haslam D.W., James W.P. Obesity. Lancet 2005, 366(9492):1197-1209.
5. Stefan M., Iglesia Lino L., Fernandez G. Medical consultation and best practices for preoperative evaluation of elderly patients. Hosp Pract (Minneap) 2011, 39(1):41-51.
6. Physical status: the use and interpretation of anthropometry. World Health Organ Tech Rep Ser 1995, 854:1-452. Report of a WHO Expert Committee.
7. Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser 2000, 894(i-xii):1-253. Report of a WHO consultation.
8. Lucreziotti S., Foroni C., Fiorentini C. Perioperative myocardial infarction in noncardiac surgery: the diagnostic and prognostic role of cardiac troponins. J Intern Med 2002, 252(1):11-20.
9. Dunkelgrun M., Schreiner F., Schockman D.B., et al. Usefulness of preoperative oral glucose tolerance testing for perioperative risk stratification in patients scheduled for elective vascular surgery. Am J Cardiol 2008, 101(4):526-529.
10. Ryding A.D., Kumar S., Worthington A.M., Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 2009, 111(2):311-319.
11. Wu W.C., Schifftner T.L., Henderson W.G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007, 297(22):2481-2488.
12. Poldermans D., Bax J.J., Boersma E., et al. European Society of cardiology task force for preoperative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009, 30(22):2769-2812.
13. Kehlet H., Mythen M. Why is the surgical high-risk patient still at risk?. Br J Anaesth 2011, 106(3):289-291.
14. Barnett S., Moonesinghe S.R. Clinical risk scores to guide perioperative management. Postgrad Med J 2011, 87(1030):535-541.
15. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113(6):898-918.
16. Bogers R.P., Bemelmans W.J., Hoogenveen R.T., et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007, 167(16):1720-1728.
17. Pascual M., Pascual D.A., Soria F., et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 2003, 89(10):1152-1156.
18. Berrington de Gonzalez A., Hartge P., Cerhan J.R., et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010, 363(23):2211-2219.
19. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005, 293(15):1861-1867.
20. Flum D.R., Belle S.H., King W.C., et al. Longitudinal Assessment of Bariatric Surgery Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009, 361(5):445-454.
21. De Hert S., Imberger G., Carlisle J., et al. Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2011, 28(10):684-722.
22. Dindo D., Muller M.K., Weber M., Clavien P.A. Obesity in general elective surgery. Lancet 2003, 361(9374):2032-2035.
23. Giles K.A., Hamdan A.D., Pomposelli F.B., et al. Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg 2010, 24(1):48-56.
24. Giles K.A., Wyers M.C., Pomposelli F.B., et al. The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-2007. J Vasc Surg 2010, 52(6):1471-1477.
25. Morgan M.A., Lewis W.G., Hopper A.N., et al. Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus 2007, 20(1):29-35.
26. Mullen J.T., Davenport D.L., Hutter M.M., et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol 2008, 15(8):2164-2172.
27. Mullen J.T., Moorman D.W., Davenport D.L. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg 2009, 250(1):166-172.
28. Kulig J., Sierzega M., Kolodziejczyk P., et al. Implications of overweight in gastric cancer: a multicenter study in a Western patient population. Eur J Surg Oncol 2010, 36(10):969-976.
29. Tokunaga M., Hiki N., Fukunaga T., et al. Better 5-year survival rate following curative gastrectomy in overweight patients. Ann Surg Oncol 2009, 16(12):3245-3251.
30. Tsai S., Choti M.A., Assumpcao L., et al. Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg 2010, 14(7):1143-1150.
31. Reeves B.C., Ascione R., Chamberlain M.H., Angelini G.D. Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol 2003, 42(4):668-676.
32. Shirzad M., Karimi A., Armadi S.H., et al. Effects of body mass index on early outcome of coronary artery bypass surgery. Minerva Chir 2009, 64(1):17-23.
33. Habib R.H., Zacharias A., Schwann T.A., et al. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis. Ann Thorac Surg 2005, 79(6):1976-1986.
34. Prabhakar G., Haan C.K., Peterson E.D., et al. The risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: a study from the Society of Thoracic Surgeons' database. Ann Thorac Surg 2002, 74(4):1125-1130. discussion 30-1.
35. Birkmeyer N.J., Charlesworth D.C., Hernandez F., et al. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1998, 97(17):1689-1694.
36. Engel A.M., McDonough S., Smith J.M. Does an obese body mass index affect hospital outcomes after coronary artery bypass graft surgery?. Ann Thorac Surg 2009, 88(6):1793-1800.
37. Oreopoulos A., Padwal R., Norris C.M., et al. Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obes (Silver Spring) 2008, 16(2):442-450.
38. Potapov E.V., Loebe M., Anker S., et al. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J 2003, 24(21):1933-1941.
39. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349(9064):1498-1504.
40. Menotti A., Blackburn H., Kromhout D., et al. Cardiovascular risk factors as determinants of 25-year all-cause mortality in the seven countries study. Eur J Epidemiol 2001, 17(4):337-346.
41. Kalantar-Zadeh K., Block G., Humphreys M.H., Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003, 63(3):793-808.
42. Kalantar-Zadeh K., Block G., Horwich T., Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43(8):1439-1444.
43. Kovesdy C.P., Anderson J.E. Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis. Semin Dial 2007, 20(6):566-569.
44. Horwich T.B., Fonarow G.C. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial 2007, 20(6):549-553.
45. Galal W., van Gestel Y.R., Hoeks S.E., et al. The obesity paradox in patients with peripheral arterial disease. Chest 2008, 134(5):925-930.
46. Butler J., Howser R., Portner P.M., Pierson R.N. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 2005, 79(1):66-73.
47. Del Prete J.C., Bakaeen F.G., Dao T.K., et al. The impact of obesity on long-term survival after coronary artery bypass grafting. J Surg Res 2010, 163(1):7-11.
48. Rahmanian P.B., Adams D.H., Castillo J.G., et al. Impact of body mass index on early outcome and late survival in patients undergoing coronary artery bypass grafting or valve surgery or both. Am J Cardiol 2007, 100(11):1702-1708.
49. Badheka A.O., Rathod A., Kizilbash M.A., et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am J Med 2010, 123(7):646-651.
50. Buettner H.J., Mueller C., Gick M., et al. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 2007, 28(14):1694-1701.
51. Diercks D.B., Roe M.T., Mulgund J., et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the CAN rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 2006, 152(1):140-148.
52. Guenette J.A., Jensen D., O'Donnell D.E. Respiratory function and the obesity paradox. Curr Opin Clin Nutr Metab Care 2010, 13(6):618-624.
53. Landi F., Onder G., Gambassi G., et al. Body mass index and mortality among hospitalized patients. Arch Intern Med 2000, 160(17):2641-2644.
54. Oreopoulos A., Padwal R., Kalantar-Zadeh K., et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J 2008, 156(1):13-22.
55. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368(9536):666-678.
56. Tremblay A., Bandi V. Impact of body mass index on outcomes following critical care. Chest 2003, 123(4):1202-1207.
57. Kalantar-Zadeh K., Kopple J.D. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 2006, 151:57-69.
58. Singh J.A., Sperling J.W., Cofield R.H. Ninety day mortality and its predictors after primary shoulder arthroplasty: an analysis of 4,019 patients from 1976-2008. BMC Musculoskelet Disord 2011, 12:231.
59. Zheng W., McLerran D.F., Rolland B., et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011, 364(8):719-729.
60. Orpana H.M., Berthelot J.M., Kaplan M.S., et al. BMI and mortality: results from a national longitudinal study of Canadian adults. Obes (Silver Spring) 2010, 18(1):214-218.
61. Gallagher D., Visser M., Sepulveda D., et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?. Am J Epidemiol 1996, 143(3):228-239.
62. Romero-Corral A., Somers V.K., Sierra-Johnson J., et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes (Lond) 2008, 32(6):959-966.
63. Schneider H.J., Friedrich N., Klotsche J., et al. The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab 2010, 95(4):1777-1785.
64. Jacobs E.J., Newton C.C., Wang Y., et al. Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med 2010, 170(15):1293-1301.
65. Welborn T.A., Dhaliwal S.S. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007, 61(12):1373-1379.
66. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298(17):2028-2037.
67. Whitlock G., Lewington S., Sherliker P., et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373(9669):1083-1096.
68. Ferrari R. The role of TNF in cardiovascular disease. Pharmacol Res 1999, 40(2):97-105.
69. Mohamed-Ali V., Goodrick S., Bulmer K., et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999, 277(6 Pt 1):E971-E975.
70. Hopkins T.A., Ouchi N., Shibata R., Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007, 74(1):11-18.
71. Manolopoulos K.N., Karpe F., Frayn K.N. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010, 34(6):949-959.
72. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002, 71:635-700.
73. Lassenius M.I., Pietilainen K.H., Kaartinen K., et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011, 34(8):1809-1815.
74. Szeto C.C., Kwan B.C., Chow K.M., et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 2008, 3(2):431-436.
75. Niebauer J., Volk H.D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999, 353(9167):1838-1842.
76. Rauchhaus M., Coats A.J., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 2000, 356(9233):930-933.
77. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005, 293(15):1868-1874.
78. Smolina K., Wright F.L., Rayner M., Goldacre M.J. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012, 344:d8059.
79. Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999, 353(9164):1547-1557.
80. Dyer A.R., Stamler J., Garside D.B., Greenland P. Long-term consequences of body mass index for cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. Ann Epidemiol 2004, 14(2):101-108.
81. Prentice A.M. Early influences on human energy regulation: thrifty genotypes and thrifty phenotypes. Physiol Behav 2005, 86(5):640-645.
82. Paradies Y.C., Montoya M.J., Fullerton S.M. Racialized genetics and the study of complex diseases: the thrifty genotype revisited. Perspect Biol Med 2007, 50(2):203-227.
83. Farooqi I.S., Keogh J.M., Yeo G.S., et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003, 348(12):1085-1095.
84. Loktionov A. Common gene polymorphisms and nutrition: emerging links with pathogenesis of multifactorial chronic diseases (review). J Nutr Biochem 2003, 14(8):426-451.
85. Farooqi S., O'Rahilly S. Genetics of obesity in humans. Endocr Rev 2006, 27(7):710-718.
86. Willett W.C., Dietz W.H., Colditz G.A. Guidelines for healthy weight. N Engl J Med 1999, 341(6):427-434.
87. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(10):1005-1012.
88. Gosker H.R., Zeegers M.P., Wouters E.F., Schols A.M. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007, 62(11):944-949.
89. Swallow E.B., Reyes D., Hopkinson N.S., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62(2):115-120.
90. Gosker H.R., van Mameren H., van Dijk P.J., et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 2002, 19(4):617-625.
91. Morley J.E., Thomas D.R., Wilson M.M. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006, 83(4):735-743.
92. Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial 2009, 22(6):636-643.
93. Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next?. Semin Dial 2005, 18(5):365-369.
94. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867.
95. Windsor J.A., Hill G.L. Weight loss with physiologic impairment. A basic indicator of surgical risk. Ann Surg 1988, 207(3):290-296.
96. Palma S., Cosano A., Mariscal M., et al. Cholesterol and serum albumin as risk factors for death in patients undergoing general surgery. Br J Surg 2007, 94(3):369-375.
97. Gibbs J., Cull W., Henderson W., et al. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999, 134(1):36-42.
98. Hennessey D.B., Burke J.P., Ni-Dhonochu T., et al. Preoperative hypoalbuminemia is an independent risk factor for the development of surgical site infection following gastrointestinal surgery: a multi-institutional study. Ann Surg 2010, 252(2):325-329.
99. Anthony P.S. Nutrition screening tools for hospitalized patients. Nutr Clin Pract 2008, 23(4):373-382.
100. Braga M., Gianotti L., Nespoli L., Radaelli G., Di Carlo V. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002, 137(2):174-180.
101. Klek S., Sierzega M., Szybinski P., et al. Perioperative nutrition in malnourished surgical cancer patients - a prospective, randomized, controlled clinical trial. Clin Nutr 2011, 30(6):708-713.
102. Braga M., Ljungqvist O., Soeters P., et al. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr 2009, 28(4):378-386.
103. Weimann A., Braga M., Harsanyi L., et al. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 2006, 25(2):224-244.